# Nutriband (NTRB) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/NTRB
## Company Profile
- Ticker: NTRB
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 5.63 USD
- Market cap: 43153739.65 USD
- Last updated: 2026-09-03
## Business Overview
Nutriband is a specialty drug-delivery company focused on transdermal technologies and abuse-deterrent patch platforms. Its story is centered on formulation science and the possibility of licensing or commercializing delivery systems for regulated products.
## Why The Stock Is Moving

As of Sep 3, 2026, NTRB closed up 19.8% at $5.63. No new same-company headline was identified in the current news window.

## Geographic Base

Nutriband is headquartered in the United States and listed on NASDAQ, with a small-cap specialty drug-delivery profile. It sits in the pharmaceutical technology niche rather than broad biotech.

## Business Model

The business depends on product development, regulatory progress, and partner interest in the delivery platform. Investors typically watch licensing, formulation updates, and the company's ability to create value from a narrow technology base.

## Landscape Position

Nutriband occupies a niche position in drug delivery and abuse-deterrent formulation. It is more of a platform story than a classic therapeutics stock.

## Future Catalysts

- Nutriband’s catalysts are Aversa-related transdermal abuse-deterrent development and any regulatory step that keeps the platform credible. The company still needs a practical commercialization path.

## Recent News
- 2026-08-13 11:00 EST — [Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight](https://biopharmsignal.com/news/NTRB/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life-sciences-summi-97bc4493) — Source: Nutriband
- 2026-05-15 11:00 EST — [Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference](https://biopharmsignal.com/news/NTRB/nutriband-inc-to-showcase-expanding-ai-wellness-product-portfolio-and-new-june-p-84b69db9) — Source: Nutriband
- 2026-04-22 11:00 EST — [Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast](https://biopharmsignal.com/news/NTRB/nutriband-ceo-gareth-sheridan-discusses-the-us-fentanyl-crisis-and-company-updat-88a89417) — Source: Nutriband
- 2026-03-30 20:05 EST — [Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch](https://biopharmsignal.com/news/NTRB/nutriband-selects-commercial-brand-name-for-its-abuse-deterrent-fentanyl-patch-08ec44c0) — Source: Nutriband
- 2026-03-18 11:00 EST — [Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica](https://biopharmsignal.com/news/NTRB/nutriband-ai-kinesiology-tapes-approved-for-distribution-and-sale-in-costa-rica-550f57ba) — Source: Nutriband